The world’s first widespread human testing of a flu vaccine which NIHR Oxford BRC researchers hope will protect more over 65-year-olds against influenza has begun in the NHS.
More than 10,000 people aged 65 and over will be asked to take part in a study supported by the National Institute for Health Research (NIHR) and delivered by the University of Oxford in Berkshire and Oxfordshire.
For the full story on Oxford Biomedical Research Centre website